PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 12 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Clinical evidence
A case report suggests potential efficacy of Grindelia spp. for relieving mild-to-moderate poison ivy dermatitis [PMID:16131296].
Methanol extracts of Grindelia camporum showed significant inhibitory activity against six pathogenic and toxinogenic fungal species, including Fusarium oxysporum, F. verticillioides, Penicillium expansum, P. brevicompactum, Aspergillus flavus, and A. fumigatus [PMID:21218483].
Components of G. squarrosa essential oil showed antibacterial activity: (-)-β-Pinene against Streptococcus pneumoniae (MIC 39.1 μg/mL) and (-)-borneol showed strong activity [PMID:37175263].
Evidence summary
PubMed sources
- 1.PMID: 26119826 (2015) — Exploring diterpene metabolism in non-model species: transcriptome-enabled discovery and functional characterization of labda-7,13E-dienyl diphosphate synthase from Grindelia robusta. · The Plant journal : for cell and molecular biology
- 2.PMID: 39454950 (2024) — The crystal structure of Grindelia robusta 7,13-copalyl diphosphate synthase reveals active site features controlling catalytic specificity. · The Journal of biological chemistry
- 3.PMID: 17770060 (1984) — New crops for arid lands. · Science (New York, N.Y.)
- 4.PMID: 37175263 (2023) — Essential Oil Composition of Grindelia squarrosa from Southern Idaho. · Molecules (Basel, Switzerland)
- 5.PMID: 16131296 (2005)